예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>아시아 태평양 지질 패널 검사 시장, 제품 및 서비스(기기, 키트 및 서비스), 처방 모드(처방 기반 검사 및 OTC 기반 검사), 응용 분야( 고지혈증 , 고중성지방혈증, 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르병, 죽상경화증 및 기타), 최종 사용자(병원, 전문 진료소 및 진료실, 병리학 검사실, 진단 진료소, 외래 수술 센터, 참고 검사실, 학술 및 연구 기관 및 기타), 유통 채널(직접 입찰, 소매 약국, 온라인 판매 및 기타) - 업계 동향 및 2030년까지의 예측.
아시아 태평양 지질 패널 테스트 시장 분석 및 통찰력
아시아 태평양 지역에서 지질 패널 검사에 대한 인식이 높아지면서 시장 수요가 증가했습니다. 더 나은 건강 서비스를 위한 의료비 지출 증가도 시장 성장에 기여합니다. 주요 시장 참여자들은 이 중요한 기간 동안 다양한 서비스 출시와 승인에 집중합니다. 또한, 프로세스와 기술의 향상된 발전도 지질 패널 검사에 대한 수요 증가에 기여합니다.
아시아 태평양 지질 패널 검사 시장은 시장 참여자의 증가와 고급 서비스의 가용성으로 인해 예측 연도에 성장할 것으로 예상됩니다. 이와 함께 제조업체는 시장에서 새로운 서비스와 효율적이고 정확한 지질 패널 검사를 출시하기 위한 개발 활동에 참여하고 있습니다. 고급 의료 기술의 개발이 증가함에 따라 시장 성장이 더욱 촉진되고 있습니다. 그러나 지질 패널 검사 제품의 생산 및 상용화에 대한 엄격한 규정과 같은 어려움이 예측 기간 동안 아시아 태평양 지질 패널 검사 시장의 성장을 방해할 수 있습니다.
Data Bridge Market Research에 따르면 아시아 태평양 지질 패널 테스트 시장은 2030년까지 42억 7,859만 달러 규모에 도달할 것으로 예상되며, 이는 예측 기간 동안 연평균 성장률 8.3%를 기록할 것으로 예상됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
매출은 백만, 볼륨은 단위, 가격은 USD |
|
다루는 세그먼트 |
제품 및 서비스(기기, 키트 및 서비스), 처방 모드(처방 기반 테스트 및 OTC 기반 테스트), 애플리케이션(고지혈증, 고중성지방혈증 , 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르병, 죽상경화증 및 기타), 최종 사용자(병원, 전문 클리닉 및 의사 사무실, 병리학 실험실, 진단 클리닉, 외래 수술 센터, 참조 실험실, 학술 및 연구 기관 및 기타), 유통 채널(직접 입찰, 소매 약국, 온라인 판매 및 기타) |
|
적용 국가 |
미국, 캐나다, 멕시코, 독일, 프랑스, 영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 유럽의 나머지 지역, 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 아시아 태평양의 나머지 지역, 브라질, 아르헨티나, 남미의 나머지 지역, 남아프리카, 사우디 아라비아, UAE, 이집트, 이스라엘, 중동 및 아프리카의 나머지 지역 |
|
시장 참여자 포함 |
아시아 태평양 지질 패널 검사 시장을 거래하는 몇몇 주요 기업으로는 Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Danaher 자회사), Sekisui Diagnostics (SEKISUI Chemical Co. Ltd.의 일부) 등이 있습니다. |
아시아 태평양 지질 패널 테스트 시장 정의
지질 패널은 의료 서비스 제공자가 심혈관 질환 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3가지와 트리글리세리드 측정이 포함됩니다.
의료 서비스 제공자는 지질 패널을 사용하여 혈액 내 콜레스테롤을 분석하여 누군가의 심혈관 건강을 평가하고 다른 건강 상태를 진단하는 데 도움을 줍니다. 지질 패널은 혈액 내 지질로 알려진 특정 지방 분자의 존재를 평가합니다. 여러 콜레스테롤 함유 분자를 포함하여 패널 테스트로 여러 물질을 측정합니다. 지질 패널은 어린이와 성인의 심장병, 심장마비, 뇌졸중과 같은 심혈관 질환의 위험을 평가합니다.
아시아 태평양 지질 패널 테스트 시장 역학
이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 만성 질환의 유병률 증가
지질 패널은 의료 서비스 제공자가 심혈관 질환 및 기타 만성 질환의 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3회와 트리글리세리드 측정이 포함됩니다. 제공자와 의료 전문가는 대부분 지질 패널을 사용하여 콜레스테롤 수치를 선별하거나 모니터링합니다. 제공자는 때때로 췌장염, 만성 신장 질환 및 갑상선 기능 저하증을 포함하여 지질 수치에 영향을 미칠 수 있는 특정 건강 상태에 대한 진단 과정의 일부로 이를 사용합니다.
따라서 결론적으로 심혈관 질환, 만성 신장 질환, 간 질환 및 기타 만성 질환의 증가로 인해 지질 프로파일링에 대한 수요가 증가했으며, 지질 패널 검사 키트에 대한 시장 수요가 증가함에 따라 향후 몇 년 동안 아시아 태평양 지질 패널 검사 시장이 성장할 것입니다.
제지
- 테스트 패널과 관련된 높은 비용
지질 프로필 검사는 지질 패널, 콜레스테롤 프로필 또는 심장 위험 프로필입니다. 이것은 콜레스테롤과 트리글리세리드와 같은 혈액 지방 수치를 측정하는 데 도움이 되는 혈액 검사의 조합입니다. 이러한 콜레스테롤과 트리글리세리드는 좋은 유형의 지방과 나쁜 유형의 지방입니다.
테스트 패널은 개발 프로세스에 막대한 비용이 필요합니다. 컨셉을 확정해야 하므로 재료를 조달해야 하며 리드 타임을 고려하는 것이 중요합니다. 또한, 기기 설계가 시장에 출시되기 전에 완전히 성숙할 수 있는 충분한 시간이 필요하기 때문에 프로세스가 시간이 많이 걸립니다.
또한, 재검증해야 하는 변경 사항은 시간에 영향을 미칩니다. 바이오센서 분석 형식과 기타 보완 기술의 발전으로 성공적인 운영을 위한 효과적인 투자와 프로젝트 위험 관리 계획이 필요했습니다. 연구를 수행하기 위한 R&D를 구축하는 데는 많은 비용이 수반되어 값비싼 장치가 필요합니다. 따라서 이 요인은 아시아 태평양 지질 패널 테스트 시장의 주요 제약입니다.
기회
기술 발전의 성장
지질 패널은 의료 서비스 제공자가 심혈관 질환 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3가지와 트리글리세리드 측정이 포함됩니다.
지질 패널 검사의 기술적 발전은 다양한 지질 패널 검사에 사용되는 방식에 따라 정확도, 민감도, 성공률, 새로운 소재를 추가로 향상시킵니다. 진단 및 검사 절차에 사용되는 첨단 기술 기반 지질 패널 검사 장치와 제품의 상용화는 소비자 수요를 증가시켜 시장 수요를 촉진합니다.
따라서 지질 패널 시험 방법의 기술적 진보와 개발은 아시아 태평양 지질 패널 시험 시장의 성장을 촉진할 것으로 예상됩니다.
도전
숙련되고 인증된 전문가의 부족
숙련되고 인증된 전문가에 대한 요구는 지질 패널 검사에 큰 과제입니다. 비만, 심혈관 질환 및 콜레스테롤 아시아 태평양 지역의 증가로 인해 진단을 위한 지질 패널 검사에 대한 수요가 증가하고 있습니다. 그러나 진단 센터의 숙련된 전문가가 부족하여 시장 성장을 방해하고 있습니다.
지질 패널 검사 진단의 도구, 방법 및 절차는 발전했지만 표준화, 평등화 및 지식에 일정한 격차가 있습니다. 기술자는 문제와 관련된 기술 교육 격차에 직면하고 고급 방법을 안전하게 적용하여 절차를 효율적으로 수행합니다. 지질 패널 검사에서 방법 개발, 검증, 운영 및 문제 해결을 위해 숙련된 전문가가 매우 필요합니다.
아시아 태평양 지질 패널 테스트 시장에 대한 COVID-19 이후 영향 분석
코로나19는 2020년 초부터 환자 수가 급격히 감소하면서 진단 분야에 큰 타격을 입혔습니다. 이 팬데믹은 사람들 사이에 섬뜩한 공포감을 조성했고, 결국 병원/클리닉과 실험실 방문에 영향을 미쳤습니다. 정기 검진은 번거롭고 스트레스가 많고 시간이 많이 걸렸습니다. 전반적인 진단 분야가 쇠퇴한 것처럼 보였지만, 가정 진단 분야는 새로운 계획에서 희망의 빛이었습니다.
최근 개발 사항
- 2022년 10월, Eurofins Scientific은 플랑드르 정부의 건강 및 보건 기관에서 의뢰한 혈액 안트렙의 PFAS(폴리플루오로알킬)에 대한 가장 큰 유럽 생물 모니터링 프로젝트의 시작을 발표했습니다. 이 제품 출시는 회사의 제품 포트폴리오 확장에 도움이 되었습니다.
- 2022년 12월, Laboratory Corporation of America Holdings는 로스앤젤레스에 있는 새롭고 더 큰 해부병리학 및 조직학 실험실에서 운영을 시작했다고 발표했습니다. 이 새로운 운영은 회사가 아시아 태평양 중앙 실험실 역량을 확장하는 데 도움이 되었습니다.
아시아 태평양 지질 패널 테스트 시장 범위
아시아 태평양 지질 패널 테스트 시장은 제품 및 서비스, 처방 모드, 애플리케이션, 최종 사용자 및 유통 채널과 같은 5가지 주요 세그먼트로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 애플리케이션 영역과 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
제품 및 서비스
- 장치
- 키트
- 서비스
아시아 태평양 지질 패널 검사 시장은 제품과 서비스를 기준으로 장비, 키트, 서비스로 구분됩니다.
처방 모드
- 처방 기반 테스트
- OTC 기반 테스트
아시아 태평양 지질 패널 검사 시장은 처방 방식을 기준으로 처방 기반 검사와 OTC 기반 검사로 구분됩니다.
애플리케이션
- 고지혈증
- 고트리글리세리드혈증
- 가족성 고콜레스테롤혈증
- 저지방단백혈증
- 탕헤르 질병
- 동맥경화증
- 기타
아시아 태평양 지질 패널 검사 시장은 응용 프로그램을 기준으로 고지혈증, 고중성지방혈증, 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르 질환, 죽상경화증 및 기타로 구분됩니다.
최종 사용자
- 병원
- 전문 진료소 및 의사 사무실
- 병리학 실험실
- 진단 클리닉
- 외래 수술 센터
- 참조 연구실
- 학술 및 연구 기관
- 기타
아시아 태평양 지질 패널 검사 시장은 최종 사용자를 기준으로 병원, 전문 진료소 및 의사 진료소, 병리학 실험실, 진단 클리닉, 외래 수술 센터, 표준 실험실, 학술 및 연구 기관 등으로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 약국
- 온라인 판매
- 기타
아시아 태평양 지질 패널 검사 시장은 유통 채널을 기준으로 직접 입찰, 소매 약국, 온라인 판매 및 기타로 구분됩니다.
아시아 태평양 지질 패널 테스트 시장 지역 분석/통찰력
아시아 태평양 지질 패널 검사 시장은 제품 및 서비스, 처방 모드, 애플리케이션, 최종 사용자, 유통 채널의 5가지 주요 부문으로 분류됩니다.
이 시장 보고서에서 다루는 국가는 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 그리고 기타 아시아 태평양 지역입니다.
2023년에는 중국이 첨단 기술 프로세스에 대한 고객 선호도가 높아지면서 아시아 태평양 지역을 장악하게 될 것입니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 아시아 태평양 지질 패널 테스트 시장 점유율 분석
아시아 태평양 지질 패널 테스트 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭 및 호흡, 응용 프로그램 우세, 제품 유형 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 아시아 태평양 지질 패널 테스트 시장에 대한 회사의 초점과만 관련이 있습니다.
아시아 태평양 지질 패널 검사 시장에서 거래하는 주요 기업으로는 Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Danaher 자회사), Sekisui Diagnostics (SEKISUI Chemical Co. Ltd.의 일부) 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC LIPID PANEL TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS & SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
5.1 KEY PRICING STRATEGY
6 ASIA PACIFIC LIPID PANEL TESTING MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN JAPAN
6.2 REGULATORY SCENARIO IN CHINA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA
7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS
7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING
7.2 RESTRAINTS
7.2.1 STRICT GOVERNMENT REGULATIONS
7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE
7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING
7.4 CHALLENGES
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS
7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING
8 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES
8.1 OVERVIEW
8.2 SERVICES
8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
8.2.2 TOTAL CHOLESTEROL TEST
8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
8.2.4 TRIGLYCERIDES/ VLDL TEST
8.2.5 NON-HDL CHOLESTEROL TEST
8.2.6 OTHERS
8.3 KITS
8.3.1 STRIPS
8.3.1.1 THREE-ANALYTE TEST STRIPS
8.3.1.2 DUAL-ANALYTE TEST STRIPS
8.3.1.3 SINGLE-ANALYTE TEST STRIPS
8.3.2 LANCETS
8.3.3 CONTROLS
8.3.3.1 MULTI-CHEMISTRY CONTROLS
8.3.3.2 HDL CHOLESTEROL CONTROLS
8.3.3.3 OTHERS
8.3.4 CAPILLARY TUBES
8.4 DEVICES
8.4.1 BY MODALITY
8.4.1.1 STANDALONE
8.4.1.2 HANDHELD
8.4.1.3 PORTABLE
8.4.2 BY TYPE
8.4.2.1 LABORATORY BASED
8.4.2.2 POINT OF CARE BASED
9 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OTC-BASED TESTING
10 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HYPERLIPIDEMIA
10.2.1 TOTAL CHOLESTEROL TEST
10.2.2 TRIGLYCERIDES/ VLDL TEST
10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.2.5 NON-HDL CHOLESTEROL TEST
10.2.6 OTHERS
10.3 HYPERTRIGLYCERIDEMIA
10.3.1 TRIGLYCERIDES/ VLDL TEST
10.3.2 TOTAL CHOLESTEROL TEST
10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.3.5 NON-HDL CHOLESTEROL TEST
10.3.6 OTHERS
10.4 ATHEROSCLEROSIS
10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.4.2 TOTAL CHOLESTEROL TEST
10.4.3 TRIGLYCERIDES/ VLDL TEST
10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.4.5 NON-HDL CHOLESTEROL TEST
10.4.6 OTHERS
10.5 FAMILIAL HYPERCHOLESTEROLEMIA
10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.5.2 TOTAL CHOLESTEROL TEST
10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.5.4 TRIGLYCERIDES/ VLDL TEST
10.5.5 NON-HDL CHOLESTEROL TEST
10.5.6 OTHERS
10.6 HYPO LIPOPROTEINEMIA
10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.6.3 TRIGLYCERIDES/ VLDL TEST
10.6.4 TOTAL CHOLESTEROL TEST
10.6.5 NON-HDL CHOLESTEROL TEST
10.6.6 OTHERS
10.7 TANGIER DISEASE
10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.7.3 TOTAL CHOLESTEROL TEST
10.7.4 TRIGLYCERIDES/ VLDL TEST
10.7.5 NON-HDL CHOLESTEROL TEST
10.7.6 OTHERS
10.8 OTHERS
11 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 PRIVATE
11.2.1.1.1 SERVICES
11.2.1.1.2 KITS
11.2.1.1.3 DEVICES
11.2.1.2 PUBLIC
11.2.1.2.1 SERVICES
11.2.1.2.2 KITS
11.2.1.2.3 DEVICES
11.2.2 BY TIER
11.2.2.1 TIER 1
11.2.2.1.1 SERVICES
11.2.2.1.2 KITS
11.2.2.1.3 DEVICES
11.2.2.2 TIER 2
11.2.2.2.1 SERVICES
11.2.2.2.2 KITS
11.2.2.2.3 DEVICES
11.2.2.3 TIER 3
11.2.2.3.1 SERVICES
11.2.2.3.2 KITS
11.2.2.3.3 DEVICES
11.3 DIAGNOSTIC CLINICS
11.3.1 SERVICES
11.3.2 KITS
11.3.3 DEVICES
11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES
11.4.1 SERVICES
11.4.2 KITS
11.4.3 DEVICES
11.5 REFERENCE LABORATORIES
11.5.1 SERVICES
11.5.2 KITS
11.5.3 DEVICES
11.6 AMBULATORY SURGICAL CENTERS
11.6.1 SERVICES
11.6.2 KITS
11.6.3 DEVICES
11.7 PATHOLOGY LABORATORIES
11.7.1 SERVICES
11.7.2 KITS
11.7.3 DEVICES
11.8 ACADEMIC AND RESEARCH INSTITUTES
11.8.1 SERVICES
11.8.2 KITS
11.8.3 DEVICES
11.9 OTHERS
12 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.3.1 HOSPITAL PHARMACIES
12.3.2 DRUG STORES
12.3.3 OTHERS
12.4 ONLINE SALES
12.5 OTHERS
13 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 AUSTRALIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 PHILIPPINES
13.1.10 INDONESIA
13.1.11 REST OF ASIA-PACIFC
14 ASIA PACIFIC LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 ASIA PACIFIC LIPID PANEL TESTING MARKET, COMPANY PROFILE
16.1 QUEST DIAGNOSTICS INCORPORATED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 EUROFINS SCIENTIFIC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 F. HOFFMANN-LA ROCHE LTD.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 RANDOX LABORATORIES LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ABBOTT
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 COMPANY SHARE ANALYSIS
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENT
16.7 AWARENESS TECHNOLOGY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ARUP LABORATORIES
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 BOSTON HEART DIAGNOSTICS CORPORATION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CPC DIAGNOSTICS
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 CRODA INTERNATIONAL PLC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 DIATRON
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EKF DIAGNOSTICS
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 EVERLYWELL, INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 ELITECH GROUP
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 HORIBA MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MYLAB BOX
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 NOVA BIOMEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PTS DIAGNOSTICS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SIEMENS HEALTHCARE GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 SINOCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 SD BIOSENSOR, INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENTS
16.26 SPARK DIAGNOSTICS PVT. LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-
TABLE 2 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 ASIA PACIFIC PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 ASIA PACIFIC DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 ASIA PACIFIC RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 55 ASIA PACIFIC ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 ASIA PACIFIC OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 59 ASIA-PACIFIC SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 ASIA-PACIFIC SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 61 ASIA-PACIFIC KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 ASIA-PACIFIC DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 67 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 68 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 ASIA-PACIFIC HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 ASIA-PACIFIC HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 ASIA-PACIFIC FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 ASIA-PACIFIC HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 ASIA-PACIFIC TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 ASIA-PACIFIC HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 ASIA-PACIFIC PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 ASIA-PACIFIC PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 ASIA-PACIFIC HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 ASIA-PACIFIC TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 ASIA-PACIFIC PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 ASIA-PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 ASIA-PACIFIC RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 91 CHINA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 92 CHINA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 CHINA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 94 CHINA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 95 CHINA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 CHINA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 CHINA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 CHINA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 99 CHINA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 CHINA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 101 CHINA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 102 CHINA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 103 CHINA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 CHINA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 CHINA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 CHINA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 CHINA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 CHINA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 CHINA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 CHINA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 CHINA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 CHINA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 CHINA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 CHINA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 115 CHINA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 CHINA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 CHINA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 CHINA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 CHINA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 CHINA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 CHINA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 CHINA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 123 CHINA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 124 CHINA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 CHINA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 JAPAN LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 127 JAPAN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 JAPAN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 129 JAPAN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 130 JAPAN KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 JAPAN STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 JAPAN CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 JAPAN DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 134 JAPAN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 JAPAN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 136 JAPAN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 137 JAPAN LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 138 JAPAN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 JAPAN HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 JAPAN HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 JAPAN ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 JAPAN FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 JAPAN HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 JAPAN TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 JAPAN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 146 JAPAN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 147 JAPAN PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 JAPAN PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 JAPAN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 150 JAPAN TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 JAPAN TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 JAPAN TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 JAPAN DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 JAPAN SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 155 JAPAN REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 JAPAN AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 JAPAN PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 JAPAN ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 JAPAN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 JAPAN RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 161 INDIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 162 INDIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 INDIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 164 INDIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 165 INDIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 INDIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 INDIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 INDIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 169 INDIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 INDIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 171 INDIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 172 INDIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 173 INDIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 INDIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 INDIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 INDIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 INDIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 INDIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 INDIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 INDIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 INDIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 INDIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 INDIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 INDIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 185 INDIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 INDIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 INDIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 INDIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 INDIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 190 INDIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 INDIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 INDIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 INDIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 194 INDIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 195 INDIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 196 AUSTRALIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 197 AUSTRALIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 198 AUSTRALIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 199 AUSTRALIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 200 AUSTRALIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 AUSTRALIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 203 AUSTRALIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 204 AUSTRALIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 AUSTRALIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 206 AUSTRALIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 207 AUSTRALIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 208 AUSTRALIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 AUSTRALIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 210 AUSTRALIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 AUSTRALIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 AUSTRALIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 AUSTRALIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 AUSTRALIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 AUSTRALIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 217 AUSTRALIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 218 AUSTRALIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 AUSTRALIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 220 AUSTRALIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 221 AUSTRALIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 223 AUSTRALIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 224 AUSTRALIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 225 AUSTRALIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 AUSTRALIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 AUSTRALIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 228 AUSTRALIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 AUSTRALIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 230 AUSTRALIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 SOUTH KOREA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 232 SOUTH KOREA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 SOUTH KOREA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 234 SOUTH KOREA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 235 SOUTH KOREA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 SOUTH KOREA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 237 SOUTH KOREA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 238 SOUTH KOREA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 239 SOUTH KOREA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 SOUTH KOREA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 241 SOUTH KOREA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 242 SOUTH KOREA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 243 SOUTH KOREA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 SOUTH KOREA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 SOUTH KOREA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 SOUTH KOREA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 SOUTH KOREA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 SOUTH KOREA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 SOUTH KOREA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 SOUTH KOREA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 SOUTH KOREA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 SOUTH KOREA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 SOUTH KOREA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 SOUTH KOREA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 255 SOUTH KOREA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 SOUTH KOREA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 SOUTH KOREA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 SOUTH KOREA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 SOUTH KOREA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 SOUTH KOREA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 SOUTH KOREA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 262 SOUTH KOREA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 SOUTH KOREA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 264 SOUTH KOREA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 SOUTH KOREA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 SINGAPORE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 267 SINGAPORE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 268 SINGAPORE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 269 SINGAPORE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 270 SINGAPORE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 271 SINGAPORE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 272 SINGAPORE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 273 SINGAPORE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 274 SINGAPORE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 SINGAPORE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 276 SINGAPORE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 277 SINGAPORE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 278 SINGAPORE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 279 SINGAPORE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 280 SINGAPORE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 281 SINGAPORE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 282 SINGAPORE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 283 SINGAPORE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 284 SINGAPORE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 285 SINGAPORE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 286 SINGAPORE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SINGAPORE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 288 SINGAPORE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 289 SINGAPORE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 290 SINGAPORE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 291 SINGAPORE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 292 SINGAPORE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 293 SINGAPORE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 294 SINGAPORE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 295 SINGAPORE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 296 SINGAPORE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 297 SINGAPORE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 298 SINGAPORE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 299 SINGAPORE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 300 SINGAPORE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 301 MALAYSIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 302 MALAYSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 303 MALAYSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 304 MALAYSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 305 MALAYSIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 306 MALAYSIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 307 MALAYSIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 308 MALAYSIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 309 MALAYSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 310 MALAYSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 311 MALAYSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 312 MALAYSIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 313 MALAYSIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 314 MALAYSIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 315 MALAYSIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 316 MALAYSIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 317 MALAYSIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 318 MALAYSIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 319 MALAYSIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 320 MALAYSIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 321 MALAYSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 322 MALAYSIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 323 MALAYSIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 324 MALAYSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 325 MALAYSIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 326 MALAYSIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 327 MALAYSIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 328 MALAYSIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 329 MALAYSIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 330 MALAYSIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 331 MALAYSIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 332 MALAYSIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 333 MALAYSIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 334 MALAYSIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 335 MALAYSIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 336 THAILAND LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 337 THAILAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 338 THAILAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 339 THAILAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 340 THAILAND KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 341 THAILAND STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 342 THAILAND CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 343 THAILAND DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 344 THAILAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 345 THAILAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 346 THAILAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 347 THAILAND LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 348 THAILAND LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 THAILAND HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 350 THAILAND HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 351 THAILAND ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 THAILAND FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 THAILAND HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 THAILAND TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 THAILAND LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 356 THAILAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 357 THAILAND PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 358 THAILAND PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 359 THAILAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 360 THAILAND TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 361 THAILAND TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 362 THAILAND TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 363 THAILAND DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 THAILAND SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 365 THAILAND REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 366 THAILAND AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 367 THAILAND PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 368 THAILAND ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 369 THAILAND LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 370 THAILAND RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 371 PHILIPPINES LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 372 PHILIPPINES SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 373 PHILIPPINES SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 374 PHILIPPINES SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 375 PHILIPPINES KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 376 PHILIPPINES STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 377 PHILIPPINES CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 378 PHILIPPINES DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 379 PHILIPPINES DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 380 PHILIPPINES DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 381 PHILIPPINES DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 382 PHILIPPINES LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 383 PHILIPPINES LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 384 PHILIPPINES HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 385 PHILIPPINES HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 386 PHILIPPINES ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 387 PHILIPPINES FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 388 PHILIPPINES HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 389 PHILIPPINES TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 390 PHILIPPINES LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 391 PHILIPPINES HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 392 PHILIPPINES PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 393 PHILIPPINES PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 394 PHILIPPINES HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 395 PHILIPPINES TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 396 PHILIPPINES TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 397 PHILIPPINES TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 398 PHILIPPINES DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 399 PHILIPPINES SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 400 PHILIPPINES REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 401 PHILIPPINES AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 402 PHILIPPINES PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 403 PHILIPPINES ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 404 PHILIPPINES LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 405 PHILIPPINES RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 406 INDONESIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 407 INDONESIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 408 INDONESIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 409 INDONESIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 410 INDONESIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 411 INDONESIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 412 INDONESIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 413 INDONESIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 414 INDONESIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 415 INDONESIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 416 INDONESIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 417 INDONESIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 418 INDONESIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 INDONESIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 INDONESIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 421 INDONESIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 422 INDONESIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 423 INDONESIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 424 INDONESIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 425 INDONESIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 426 INDONESIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 427 INDONESIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 428 INDONESIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 429 INDONESIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 430 INDONESIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 431 INDONESIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 432 INDONESIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 433 INDONESIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 434 INDONESIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 435 INDONESIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 436 INDONESIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 437 INDONESIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 438 INDONESIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 439 INDONESIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 440 INDONESIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 441 REST OF ASIA-PACIFIC LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 ASIA PACIFIC LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC LIPID PANEL TESTING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC LIPID PANEL TESTING MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC LIPID PANEL TESTING MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 ASIA PACIFIC LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA PACIFIC LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD
FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC LIPID PANEL TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC LIPID PANEL TESTING MARKET
FIGURE 14 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022
FIGURE 15 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022
FIGURE 19 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 20 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY APPLICATION, 2022
FIGURE 23 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY END USER, 2022
FIGURE 27 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC LIPID PANEL TESTING MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC LIPID PANEL TESTING MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)
FIGURE 39 ASIA PACIFIC LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
